Atlas Trials

Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma

Clinical trial NCT01932385 · COMPLETED

Trial details

NCT number
NCT01932385
Sponsor
Qingdao Central Hospital
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Liver Cancer
Start date
2013-08-01
Primary completion
2016-01-30
Enrollment
86

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.